North America's fentanyl death crisis: Selected lessons for Europe's future?

Benedikt Fischer, Didier Jutras-Aswad, Bernard Le Foll, Tessa Robinson
Author Information
  1. Benedikt Fischer: Faculty of Health Sciences, Centre for Applied Research in Mental Health & Addiction, Simon Fraser University, Vancouver, British Columbia, Canada; Research & Graduate Studies, University of the Fraser Valley, Abbotsford, BC, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, São Paulo, Brazil; School of Population Health, University of Auckland, Auckland, New Zealand. ORCID
  2. Didier Jutras-Aswad: Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, Canada; Department of Psychiatry & Addictology, Université de Montréal, Montreal, Canada.
  3. Bernard Le Foll: Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction & Mental Health, Toronto, Ontario, Canada; Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada.
  4. Tessa Robinson: Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Abstract

No abstract text available.

Keywords

References

  1. Drug Alcohol Rev. 2021 Sep;40(6):964-973 [PMID: 33604968]
  2. Drug Alcohol Rev. 2024 Feb;43(2):562-566 [PMID: 38098180]
  3. Drug Alcohol Depend. 2021 Aug 1;225:108799 [PMID: 34087747]
  4. Addiction. 2019 Sep;114(9):1602-1613 [PMID: 31166621]
  5. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5748 [PMID: 38158387]
  6. Addiction. 2020 Aug;115(8):1482-1493 [PMID: 31899565]
  7. PLoS One. 2022 Mar 22;17(3):e0265665 [PMID: 35316284]
  8. Int J Drug Policy. 2024 Mar;125:104339 [PMID: 38335867]
  9. J Pain Res. 2020 Dec 07;13:3281-3294 [PMID: 33324089]
  10. J Clin Pharm Ther. 2021 Dec;46(6):1501-1504 [PMID: 34111307]
  11. Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350 [PMID: 33965972]
  12. Subst Abuse Treat Prev Policy. 2021 Oct 18;16(1):79 [PMID: 34663374]
  13. Pain Physician. 2022 Mar;25(2):97-124 [PMID: 35322965]
  14. J Stud Alcohol Drugs. 2023 Nov;84(6):801-807 [PMID: 37796625]
  15. Drug Alcohol Depend. 2020 Jul 1;212:108006 [PMID: 32438280]
  16. Lancet Reg Health Am. 2023 Feb 03;19:100437 [PMID: 36950034]
  17. Harm Reduct J. 2023 Mar 28;20(1):41 [PMID: 36978170]
  18. Subst Abuse Treat Prev Policy. 2022 Mar 31;17(1):25 [PMID: 35361228]

Word Cloud

Created with Highcharts 10.0.0NorthfentanylAmerica'sdeathcrisis:SelectedlessonsEurope'sfuture?EuropeAmericadrugsfatalityinterventionsoverdosepolicypublichealthtoxicity

Similar Articles

Cited By

No available data.